載入...
Moxifloxacin Pharmacokinetic Profile and Efficacy Evaluation in Empiric Treatment of Community-Acquired Pneumonia
When antimicrobials are used empirically, pathogen MICs equal to clinical breakpoints or epidemiological cutoff values must be considered. This is to ensure that the most resistant pathogen subpopulation is appropriately targeted to prevent emergence of resistance. Accordingly, we determined the pha...
Na minha lista:
| 發表在: | Antimicrob Agents Chemother |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society for Microbiology
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4356773/ https://ncbi.nlm.nih.gov/pubmed/25666151 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.04659-14 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|